Does quinolone- or macrolide-resistant Streptococcus agalactiae bacteremia affect patient outcome? A multicenter cohort study.

Does quinolone- or macrolide-resistant Streptococcus agalactiae bacteremia affect patient outcome? A multicenter cohort study.
Jpn J Infect Dis. 2020 Oct 30;:
Authors: Mitsuboshi S, Date J, Tsuruma N, Yamaga H, Watanabe K, Kijima H, Nakashita M, Hosokawa H, Tsugita M
Abstract
The prevalence of quinolone- and macrolide-resistant Group B Streptococcus (GBS) is increasing worldwide, but the relationship between GBS resistance to these antibiotics and patient outcome remains unclear. Therefore, we evaluated whether blood stream infection caused by quinolone- or macrolide-resistant GBS is associated with high mortality. Our findings in 77 patients with GBS bacteremia demonstrate that quinolone and macrolide resistance may not be risk factors for 30-day mortality.
PMID: 33132300 [PubMed - as supplied by publisher]

Source: Japanese Journal of Infectious Diseases - October 30, 2020 Category: Infectious Diseases Authors: Mitsuboshi S, Date J, Tsuruma N, Yamaga H, Watanabe K, Kijima H, Nakashita M, Hosokawa H, Tsugita M Tags: Jpn J Infect Dis Source Type: research